BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17804485)

  • 1. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.
    Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats.
    DiBona GF; Sawin LL
    J Lab Clin Med; 2001 Aug; 138(2):119-29. PubMed ID: 11477379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neuropeptide Y and its receptors Y1 and Y2 in the rat heart and its supplying autonomic and spinal sensory ganglia in experimentally induced diabetes.
    Chottová Dvoráková M; Wiegand S; Pesta M; Slavíková J; Grau V; Reischig J; Kuncová J; Kummer W
    Neuroscience; 2008 Feb; 151(4):1016-28. PubMed ID: 18201831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
    Oellerich WF; Malik KU
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype.
    Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA
    Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex plastic changes in the neuropeptide Y system during ethanol intoxication and withdrawal in the rat brain.
    Olling JD; Ulrichsen J; Christensen DZ; Woldbye DP
    J Neurosci Res; 2009 Aug; 87(10):2386-97. PubMed ID: 19267419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
    Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
    Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen up-regulates neuropeptide Y Y1 receptor expression in a human breast cancer cell line.
    Amlal H; Faroqui S; Balasubramaniam A; Sheriff S
    Cancer Res; 2006 Apr; 66(7):3706-14. PubMed ID: 16585197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y increases in vivo hippocampal extracellular glutamate levels through Y1 receptor activation.
    Meurs A; Portelli J; Clinckers R; Balasubramaniam A; Michotte Y; Smolders I
    Neurosci Lett; 2012 Feb; 510(2):143-7. PubMed ID: 22285263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y Y1 receptors in the rat forebrain: autoradiographic demonstration of [125I][Leu31,Pro34]-NPY binding sites and neurons expressing Y1 receptor mRNA.
    Larsen PJ; Sheikh SP; Mikkelsen JD
    J Recept Signal Transduct Res; 1995; 15(1-4):457-72. PubMed ID: 8903957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression in the neuropeptide Y system during ethanol withdrawal kindling in rats.
    Olling JD; Ulrichsen J; Correll M; Woldbye DP
    Alcohol Clin Exp Res; 2010 Mar; 34(3):462-70. PubMed ID: 20028355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of neuropeptide Y Y1 receptors by testosterone in vascular smooth muscle cells in rat testis.
    Kopp J; Collin O; Villar M; Mullins D; Bergh A; Hokfelt T
    Neuroendocrinology; 2008; 88(3):216-26. PubMed ID: 18535365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent changes within the intrinsic kidney-associated NPY system and tubular function by litter size reduction.
    Alejandre Alcázar MA; Boehler E; Amann K; Klaffenbach D; Hartner A; Allabauer I; Wagner L; von Hörsten S; Plank C; Dötsch J
    Nephrol Dial Transplant; 2011 Aug; 26(8):2453-65. PubMed ID: 21367848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.